Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of CardiolRxTM on Recurrent Pericarditis An Open Label Pilot Study (MAvERIC-Pilot Study)

NCT05494788 is registered in ClinicalTrials.gov with Cardiol Therapeutics Inc. as lead sponsor.

NCT NCT05494788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05494788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of CardiolRxTM on Recurrent Pericarditis An Open Label Pilot Study (MAvERIC-Pilot Study)
Lead sponsor
Cardiol Therapeutics Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 9, 2023
Completion date
September 6, 2024
Enrollment
27 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pericarditis